Get started
Diaceutics PlcDiaceutics PlcDiaceutics Plc

Diaceutics Plc

No trades
OverviewFinancialsNewsDocumentsCommunityTechnicalsForecastsSeasonals

Chart


Full chart

Upcoming earnings


Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪140.85 M‬ GBP
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
0 GBP
Net income (FY)
‪−1.70 M‬ GBP
Revenue (FY)
‪32.16 M‬ GBP
Shares float
‪51.38 M‬
Beta (1Y)
1.05

Employees


Employees (FY)
199
Revenue / Employee (1Y)
‪161.60 K‬ GBP
Net income / Employee (1Y)
‪−8.56 K‬ GBP

About Diaceutics Plc


Sector
Health Technology
Industry
Biotechnology
CEO
Ryan Gerard Keeling
Website
diaceutics.com
Headquarters
Belfast
Founded
2005
IPO date
Mar 21, 2019
Identifiers
2
ISIN GB00BJQTGV64
Diaceutics Plc engages in the provision of data, data analytics and implementation services. It also provides insights generated from its testing data from its worldwide laboratory network to pharmaceutical companies. The company was founded in 2005 and is headquartered in Belfast, the United Kingdom.

Check out other big names from the same industry as DXRX.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

News



Technicals


Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of DXRX is 167 GBX — it hasn't changed in the past 24 hours. Watch Diaceutics Plc stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on LSE exchange Diaceutics Plc stocks are traded under the ticker DXRX.
DXRX stock has fallen by −0.89% compared to the previous week, the month change is a 16.84% rise, over the last year Diaceutics Plc has showed a 20.55% increase.
We've gathered analysts' opinions on Diaceutics Plc future price: according to them, DXRX price has a max estimate of 243.00 GBX and a min estimate of 185.00 GBX. Watch DXRX chart and read a more detailed Diaceutics Plc stock forecast: see what analysts think of Diaceutics Plc and suggest that you do with its stocks.
DXRX reached its all-time high on Jul 29, 2020 with the price of 195 GBX, and its all-time low was 74 GBX and was reached on Jan 4, 2023. View more price dynamics on DXRX chart.
See other stocks reaching their highest and lowest prices.
DXRX stock is 0.90% volatile and has beta coefficient of 1.05. Track Diaceutics Plc stock price on the chart and check out the list of the most volatile stocks — is Diaceutics Plc there?
Today Diaceutics Plc has the market capitalization of ‪140.85 M‬, it has decreased by −0.89% over the last week.
Yes, you can track Diaceutics Plc financials in yearly and quarterly reports right on TradingView.
Diaceutics Plc is going to release the next earnings report on Sep 29, 2026. Keep track of upcoming events with our Earnings Calendar.
DXRX net income for the last half-year is ‪−2.40 M‬ GBP, while the previous report showed ‪881.00 K‬ GBP of net income which accounts for −372.53% change. Track more Diaceutics Plc financial stats to get the full picture.
No, DXRX doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Feb 15, 2026, the company has 199 employees. See our rating of the largest employees — is Diaceutics Plc on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Diaceutics Plc EBITDA is ‪2.83 M‬ GBP, and current EBITDA margin is 7.25%. See more stats in Diaceutics Plc financial statements.
Like other stocks, DXRX shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Diaceutics Plc stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Diaceutics Plc technincal analysis shows the neutral today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Diaceutics Plc stock shows the buy signal. See more of Diaceutics Plc technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.